First, KAI1/CD82 enhances the expression of miR-203 and downregulates FZD2 expression, thus suppressing metastasis by inhibiting the Wnt signaling pathway in NSCLC cells [45]. Here, CD82 is linked to non-small cell lung carcinoma.